Reply #35: That you don't buy into it

[depakid]

Doesn't mean it's not true AND that public health officials (and docs and nurses in MPH programs all across the country) aren't well aware of it.

As far as CAM therapies are concerned- double blind clinical trial are expensive- but there's PLENTY of other evidence available. If there's no patent "incentive" you're not going to get much in the literature about Ginkgo, sylmarin, MSM, glucosamine sulfate, EPA's etc.

Some of the work you'll have to go overseas for- where healthcare is NOT for profit- and treatment (and prescribing habits) aren't based on pharmaceutical marketing tactics and conflicts of interests.